Emergency Use Approval for Two Vaccines
India's drug regulator, Central Drugs Standard Control Organisation, has given emergency use authorisation (EUA) to Oxford- AstraZeneca’s Covishield and Bharat Biotech’s indigenously developed Covaxin. The subject expert committee (SEC) under CDSCO has recommended Covishield, for emergency use and Covaxin for restricted use.
Approved Vaccines
- Covishield is local name for the Oxford-AstraZeneca vaccine developed in the UK. It is being manufactured by Pune-based Serum Institute of India, the world's largest vaccine manufacturer. It is made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus - although ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here